Testing for the ability to modify antibiotics of Panus tigrinus 8/18 Lentinus strigosus 1566 laccase / Teste de capacidade para modificar antibióticos a partir da lacase de Panus tigrinus 8/18 e Lentinus strigosus 1566

In advanced biotechnology, the utilization of enzymes to achieve new or modified compounds with antibacterial, fungicidal, and anti-cancer specifications is crucial. Mushroom lactases are a hopeful biocatalyst for the synthesis and modification of different compounds. They are an accessible and inexpensive enzyme for the preparation of reaction objects and have recently received attention. Laccase purification was performed from basidiomycete Lentinus strigosus (LS) in several stages: Stage 1. On ion-exchange chromatography on TEAE Servacell 23 (400 ml), two distinctly separated laccase activity peaks were observed, eluted from the carrier at 0.21 and 0.27 M NaCl. In order to reduce the loss of enzymes, all fractions with laccase activity were collected, concentrated, and desalted using an ultrafiltration cell (Amicon, United States) with a UM-10 membrane. Stage 2. The resulting preparation with laccase activity was applied to a Q-Sepharose column (60 ml). Two well-separated peaks with laccase activity were obtained during the elution: laccase I (0.12 M NaCl) and laccase II (0.2 M NaCl). Stage 3. In the course of further purification of both enzymes, carried out on anion-exchange carrier Resource Q (6 ml), a broken gradient was used: 0 - 10%, 10 - 20%, and 20 - 100% with 1M NaCl. Stage 4. Both laccase I and laccase II, obtained after Resource Q, were desalted, concentrated to 1 ml each, and applied to a Superdex 75 gel filtration column. As a result, two laccases were obtained in a homogeneous form.

Na biotecnologia moderna, o uso de enzimas para obter compostos novos ou modificados com propriedades antibacterianas, antifúngicas e anticancerígenas é crucial. Lactases de cogumelos são biocatalisadores promissores para síntese e modificação de diferentes compostos, por serem enzimas baratas e disponíveis para a preparação de componentes de reação, e vem recebendo a devida atenção recentemente. A purificação da lacase foi realizada a partir do basidiomiceto Lentinus strigosus em vários estágios: Etapa 1 - na cromatografia de troca iônica em TEAE Servacell 23 (400 ml), foram observados dois picos de atividade da lacase distintamente separados, com eluição do transportador a 0,21 e 0,27 M de NaCl. Para reduzir a perda de enzimas, todas as frações com atividade de lacase foram coletadas, concentradas e dessalinizadas em uma célula de ultrafiltração (Amicon, Estados Unidos) com membrana UM-10; Etapa 2 - a preparação resultante com atividade de lacase foi aplicada a uma coluna Q-Sepharose (60 ml). Durante a eluição, foram obtidos dois picos bem separados com atividade de lacase: lacase I (NaCl 0,12 M) e lacase II (NaCl 0,2 M); Etapa 3 - no decurso da purificação adicional de ambas as enzimas, realizada no Recurso Q de transportador de troca aniônica (6 ml), um gradiente quebrado foi usado: 0-10%, 10-20% e 20-100% com NaCl 1M; Etapa 4 - tanto a lacase I como a lacase II, obtidas após o Recurso Q, foram dessalinizadas e concentradas para 1 ml cada e aplicadas a uma coluna de filtração em gel Superdex 75. Como resultado, duas lacases foram obtidas de forma homogênea.

Cultivo in vitro de raíces pilosas del arbusto Phyllanthus acuminatus (Phyllanthaceae) / In vitro culture of hairy roots of the shrub, Phyllanthus acuminatus (Phyllanthaceae)

Introducción: En condiciones naturales, las raíces del arbusto, Phyllanthus acuminatus, producen bajas concentraciones de metabolitos secundarios de interés medicinal. Esto abre una oportunidad para el cultivo in vitro, para aumentar la concentración de metabolitos. Objetivo: Determinar las condiciones óptimas de cultivo líquido para raíces pilosas de P. acuminatus. Métodos: Se utilizó la evaluación del crecimiento de la biomasa según porcentaje de inóculo inicial (0.50 y 0.10 %), porcentaje de nutrientes de los medios (100, 50 y 25 %) y tasa de agitación (90, 100 y 110 min-1) (N= 15 repeticiones). Resultados: Las mejores condiciones de cultivo líquido fueron: 0.10 % de inóculo inicial, nutrientes al 25 % y 90 min-1 para la tasa de agitación. Hay diferencias entre las raíces pilosas y las raíces no transformadas. Conclusiones: es factible producir raíces pilosas de P. acuminatus a gran escala, aplicando e implementando las condiciones evaluadas de porcentaje de inóculo, nutrientes en el medio y tasas de agitación utilizadas en este estudio.

Introduction: Under natural conditions, the roots of the shrub, Phyllanthus acuminatus, produce low concentrations of secondary metabolites of medicinal interest. This opens an opportunity for in vitro culture, to increase metabolite concentration. Objective: To determine the optimal liquid culture conditions for hairy roots of P. acuminatus. Methods: We used biomass growth evaluation according to initial inoculum percentage (0.50 and 0.10 %), percentage of medium nutrients (100, 50 and 25 %) and agitation rate (90, 100 and 110 min-1) (N=15 replications). Results: The best liquid culture conditions were: 0.10 % of initial inoculum, nutrients at 25 % and 90 min-1 for the agitation rate. There are differences among hairy roots and non-transformed roots. Conclusions: It is feasible to produce P. acuminatus hairy roots at a large scale, applying and implementing the evaluated conditions of inoculum percentage, nutrients in the medium and agitation rates.

Tratamientos y bioterapias para COVID-19 / Therapeutics and biotherapies for covid-19

INTRODUCCIÓN: Un nuevo brote de coronavirus surgió en 2019 en Wuhan, China, causando conmoción en el sistema sanitario de todo el mundo; el Comité Internacional de Taxonomía de Virus lo denominó SARS-CoV-2, agente causante de la enfermedad COVID-19.El espectro de gravedad de la enfermedad es muy amplio: la mayoría de los pacientes no presentan gravedad, pero otros pueden desarrollar neumonías, y la insuficiencia respiratoria aguda es la causa más frecuente de mortalidad. Objetivo: analizar y desarrollar las distintas alternativas terapéuticas aportadas por la Biotecnología para tratar los síntomas de aquellos pacientes con COVID-19. Metodología: se realizó una revisión de la bibliografía disponible, a partir de enero de 2020 en PubMed, acerca de los tratamientos que se encuentran aún en ensayos clínicos y aquellos que cuentan con aprobación bajo uso de emergencia para la enfermedad COVID-19. También se realizaron búsquedas a través de Google y Google Académico para publicaciones de organismos de Salud en referencia a políticas de salud establecidas para la terapéutica durante dicha pandemia. Resultados: este trabajo aborda las nuevas alternativas terapéuticas para COVID-19 derivadas de la Biotecnología, que se encuentran tanto en uso como en etapas de ensayos clínicos comprendidos dentro del segmento de los biofármacos y las bioterapias. Se incluye un breve resumen del estatus regulatorio de entidades de salud, el mecanismo de acción de dichas terapias y características generales de cada uno. Se incluyen novedosas bioterapias que se empezaron a implementar para afrontar la pandemia. Conclusiones: la pandemia de coronavirus está poniendo a prueba el sistema sanitario internacional, para brindar soluciones tanto desde el diagnóstico y prevención como para el tratamiento de la población a fin de disminuir la mortalidad. Esto incluyó, obviamente también, al área de la Biotecnología aplicada a la salud, que ha aportado en los tres aspectos mencionados; el presente trabajo se centra en las respuestas de tipo terapéutico que ha brindado y que están comercializadas o en fases clínicas. (AU)

INTRODUCTION: A new coronavirus outbreak emerged in 2019 in Wuhan, China, causing a shock to the healthcare system around the world; the International Committee on Taxonomy of Viruses named it SARS-CoV- 2, the infectious agent of the COVID-19 disease. The spectrum of severity of the disease is very wide, most patients are not serious, but others can develop pneumonia, with acute respiratory failure being the most frequent cause of mortality. Objective: to analyze and develop the different therapeutic alternatives provided by Biotechnology dedicated to Health, to treat the symptoms of those COVID-19 patients who require it, and thus reduce mortality.Methodology: a review of the available literature from January 2020 in PubMed of the treatments that are still in clinical trials and those that have been approved under emergency use for the disease COVID-19 was performed. Searches were also carried out through Google and Google Scholar for publications of Health organizations in reference to health policies established for therapeutics during the mentioned pandemic. Results: this work addresses the new therapeutic alternatives derived from Biotechnology, which are both in use and in stages of clinical trials, to treat patients who developed COVID-19 included within the segment of biopharmaceuticals and biotherapies. A brief summary of the regulatory status of health entities, the mechanism of action of said therapies and general characteristics of each one is included. Innovative biotherapies that began to be implemented to face the pandemic are included. Conclusions: The coronavirus pandemic has driven the international health system to the test, to provide solutions both from the diagnosis, prevention and treatment of the population to reduce the mortality of patients. This obviously also included the area of Biotechnology applied to health, which has contributed in the three aspects mentioned. The present work focuses on the therapeutic responses that it has provided and that are commercialized or in clinical phases. (AU)

Biotecnología y vacunas COVID-19 / Biotechnology and vaccines COVID-19

Introducción: la enfermedad por coronavirus 2019 (COVID-19) causada por el nuevo coronavirus (SARS-CoV-2) ha planteado una emergencia médica y una crisis mundial rápidamente, desde que surgió por primera vez en diciembre de 2019. El 11 de marzo de 2020, la Organización Mundial de la Salud (OMS) declaró una pandemia. Las vacunas COVID-19 son ahora actores críticos en la situación global del SARS-CoV-2, con el objetivo de alcanzar progresivamente la inmunidad colectiva. La OMS ha aprobado 9 vacunas entre el 30 de diciembre de 2020 y el 20 de diciembre de 2021. Objetivo: el objetivo de este estudio es analizar, desde los aportes hechos por la Biotecnología, las distintas vacunas que están siendo administradas, así como también las que están en investigación y desarrollo, para la prevención del COVID-19. Materiales y métodos: se realizó una revisión exhaustiva de la literatura dedicada a vacunas aprobadas o en instancias clínicas destinadas a la prevención de COVID-19. Palabras clave: COVID-19, SARS-CoV-2, vacunas, biotecnología, vectores, y coronavirus; en las bases de datos MEDLINE/PubMed, Scielo (Scientific Electronic Library Online), Nature, Lancet y Google Scholar. Criterios de inclusión de trabajos científicos: i) idioma inglés o español, ii) publicados entre 2019-2021, iii) referidos a Biotecnología. Criterio de exclusión: i) fármacos/vacunas convencionales no aprobadas ni recomendadas por la Organización Mundial de la Salud (OMS) o el Centro de Control de Enfermedades y prevención (CDC por sus siglas en inglés) para su uso en la enfermedad causada por COVID-19. Luego, se describieron los hallazgos de los artículos seleccionados de forma cualitativa. Resultados: el presente trabajo expone los distintos tipos de plataformas vacunales desarrollados hasta el momento para enfrentar la pandemia de COVID-19. Conclusiones: debido a que las vacunas contra el COVID-19 se han desarrollado hace tan solo unos meses, aún se desconoce la duración de la inmunidad que confieren. Sin embargo, hay datos alentadores que indican que la mayoría de las personas que han sido vacunadas adquieren una inmunidad apropiada que protege contra una nueva infección, al menos durante un cierto tiempo, y permite disminuir significativamente la gravedad de esta nueva infección. (AU)

Introduction: the coronavirus disease 2019 (COVID-19) caused by the novel coronavirus (SARS-CoV-2) has quickly posed a medical emergency and global crisis, since it first emerged in December 2019. On March 11, 2020, the World Health Organization (WHO) declared a pandemic. COVID-19 vaccines are now critical players in the global SARS-CoV-2 situation, with the goal of progressively achieving herd immunity. The WHO has approved 9 vaccines between December 30, 2020 and December 20, 2021. Objective: the objective of this study is to analyze, from the contributions made by Biotechnology, the different vaccines that are being administered, as well as in research and development, for the prevention of COVID-19. Materials and methods: an exhaustive review of the literature dedicated to approved vaccines or in clinical instances intended for the treatment of COVID-19 was carried out. Key words: "COVID-19", "SARS-CoV-2", "vaccines", "biotechnology", "vectors", and "coronavirus"; in the MEDLINE/Pubmed, Scielo (Scientific Electronic Library Online), Nature, Lancet and Google Scholar databases. Criteria for the inclusion of scientific papers: i) English or Spanish language, ii) published between 2019-2021, iii) referring to Biotechnology. Exclusion criteria: i) conventional drugs/vaccines not approved or recommended by the World Health Organization (WHO) or the Center for Disease Control and Prevention (CDC) for use in disease caused by the COVID 19. Then, the findings of the selected articles were described qualitatively. Results: this study presents the pathophysiology of SARS-CoV-2 infection and the use of the different types of vaccine platforms developed to date to face the COVID-19 pandemic. Conclusions: the pandemic generated by COVID-19 has represented a great challenge around the world in many aspects, from the medical, scientific to the social and economic.Since COVID-19 vaccines were developed only a few months ago, the duration of immunity they confer is still unknown and more research is needed to answer this question. However, there is encouraging data indicating that most people who recover from the disease acquire an immunity that protects against a new infection, at least for a certain time, although to what degree and for what duration is still being determined. (AU)

Manipulação de oócitos inclusos em folículos ovarianos pré-antrais e a importância dos antioxidantes ­ revisão de literatura / Manipulation of oocytes included in preantral ovarian follicles and the importance of antioxidants ­ literature review / Manipulación de ovocitos incluidos en folículos ováricos preantrales e importancia de los antioxidantes - revisión de la literatura

A manipulação de oócitos inclusos em folículos ovarianos pré-antrais (MOIFOPA) vem sendo estudada pensando na perspectiva futura de aplicação direta na reprodução humana, principalmente para mulheres que sofrem de doenças ou que precisam passar por tratamentos que interferem na função ovariana. Nesse contexto, o objetivo deste trabalho é revisar aspectos relacionados com a biotécnica de MOIFOPA e a importância dos antioxidantes no cultivo in vitro de folículos pré-antrais. Foi realizada uma pesquisa na base de dados PubMed, buscando artigos sobre a biotécnica, principalmente relacionados com a necessidade do uso de antioxidantes no cultivo. A grande maioria dos estudos sobre a biotécnica utilizam como modelo experimental os folículos ovarianos de diferentes espécies de animais. A MOIFOPA compreende o isolamento e o resgate de folículos ovarianos pré-antrais provenientes de ovários, seguido da conservação através da técnica de resfriamento ou congelação e o cultivo folicular in vitro, a fim de promover o crescimento, a maturação e a fecundação in vitro (FIV) dos oócitos inclusos nesses folículos, maximizando o potencial reprodutivo feminino e diminuindo a atresia folicular que acontece in vivo. Um aspecto que pode interferir no sucesso do cultivo in vitro de folículos ovarianos pré-antrais é a produção em excesso de espécies reativas de oxigênio (EROs). Os ácidos ascórbico e alfa lipóico vem demonstrando resultados interessantes para reduzir os efeitos que as EROs causam sobre os folículos ovarianos pré-antrais cultivados in vitro.

The manipulation of oocytes included in preantral ovarian follicles (MOEPF) has been studied considering the future perspective of direct application in human reproduction, especially for women who suffer from diseases or who need to undergo treatments that interfere with ovarian function. In this context, the objective of this paper is to review aspects related to the biotechnology of MOIFOPA and the importance of antioxidants. A search was carried out in the PubMed database, searching for articles on biotechnology, mainly related to the need to use antioxidants in cultivation. The vast majority of studies on biotechnology use ovarian follicles from different species of animals as an experimental model. MOIFOPA comprises the isolation and rescue of preantral ovarian follicles from ovaries, followed by conservation through the cooling or freezing technique and in vitro follicular cultivation, in order to promote growth, maturation and in vitro fertilization ( IVF) of the oocytes included in these follicles, maximizing the female reproductive potential and decreasing the follicular atresia that occurs in vivo. One aspect that may interfere with the success of in vitro culture of preantral ovarian follicles is the excess production of reactive oxygen species (ROS). Ascorbic and alpha lipoic acids have shown interesting results in reducing the effects that ROS cause on in vitro cultured preantral ovarian follicles.

manipulación de ovocitos incluidos en folículos ováricos preantrales (MOIFOPA) se ha estudiado con la perspectiva futura de su aplicación directa en la reproducción humana, especialmente en mujeres que padecen enfermedades o que necesitan someterse a tratamientos que interfieren en la función ovárica. En este contexto, el objetivo de este trabajo es revisar los aspectos relacionados con la biotécnica de MOIFOPA y la importancia de los antioxidantes en el cultivo in vitro de los folículos pré-antrais. Se realizó una investigación en la base de datos PubMed, buscando artículos sobre la biotecnología, principalmente relacionados con la necesidad del uso de antioxidantes en el cultivo. La mayoría de los estudios sobre biotecnología utilizan como modelo experimental los folículos ováricos de diferentes especies de animales. El MOIFOPA incluye el aislamiento y rescate de los folículos ováricos preantrales de los ovarios, seguido de su conservación mediante la técnica de enfriamiento o congelación y el cultivo folicular in vitro, con el fin de promover el crecimiento, la maduración y la fecundación in vitro (FIV) de los ovocitos incluidos en estos folículos, maximizando el potencial reproductivo femenino y disminuyendo la atresia folicular que se produce in vivo. Un aspecto que puede interferir en el éxito del cultivo in vitro de folículos ováricos preantrales es la producción excesiva de especies reactivas de oxígeno (ROS). El ácido ascórbico y el ácido alfa lipoico han mostrado resultados interesantes para reducir los efectos que causan las ERO en los folículos ováricos preantrales cultivados in vitro.

Aportes de la biotecnología en el diagnóstico de COVID-19 / Biotechnology contributions in COVID-19 diagnosis

Introducción: en diciembre del año 2019 surgió en China una neumonía viral; el virus fue identificado como un coronavirus SARS-CoV-2, que se propagó rápidamente de tal manera que se convirtió en pandemia. La alta contagiosidad y la presencia de portadores asintomáticos dificultaron el diagnóstico de la infección y la toma de decisiones sanitarias. Objetivo: el objetivo de esta revisión bibliográfica es presentar y describir las principales técnicas utilizadas actualmente para el diagnóstico de COVID-19 y establecer su relación con los conocimientos de distintas disciplinas y tecnologías emergentes que confluyen en la Biotecnología bioquímico-farmacéutica orientada a la Salud humana. Metodología: se realizó una revisión de la bibliografía disponible en PubMed a partir de enero de 2020 sobre las pruebas diagnósticas que se encuentran actualmente en uso, en el ámbito sanitario, para la detección y seguimiento de la enfermedad COVID-19. También se realizaron búsquedas a través de Google y Google Académico para publicaciones de organismos de Salud en referencia a métodos diagnósticos. Resultados: se presenta una importante cantidad de pruebas diagnósticas, basadas en diferentes tecnologías, que desempeñan un papel clave en la pandemia de COVID-19. Algunas de ellas muy sofisticadas, como la secuenciación genómica de próxima generación, otras más estándar, pero igualmente robustas, como la reacción en cadena de la polimerasa (PCR). También otras adaptadas para el brote pandémico, como la amplificación isotérmica de ácidos nucleicos mediada por bucle. Todas las mencionadas se consideran de tipo molecular, pero también existen las pruebas serológicas, como ELISA, que incluyen ensayos en plasma o de tipo inmunológico. Estas sirven para detectar anticuerpos frente a la exposición al virus o antígenos en personas potencialmente infectadas. Conclusiones: los procesos de investigación y desarrollo biotecnológicos aplicados al diagnóstico y los conocimientos científicos previos permitieron una respuesta tanto nacional como internacional rápida y eficaz en medio de una inédita pandemia global. En esta revisión destacamos las principales técnicas, en qué estadio se deben usar y qué información nos aportan. (AU)

Introduction: in December 2019, a viral pneumonia emerged in China, identifying the virus as a SARS-CoV-2 coronavirus, which spread rapidly in such a way that it became a pandemic. The high contagiousness and the presence of asymptomatic carriers make difficulted to diagnose the infection and to make health decisions. Target: the objective of this review is to present and describe the main techniques currently used for the diagnosis of COVID-19, and to establish their relationship with the knowledge of different disciplines and emerging technologies that converge in biochemical-pharmaceutical biotechnology oriented to human health. Methodology: a review of the literature available in Pubmed from January 2020 on the diagnostic tests that are currently in use in the health field, for the detection and monitoring of COVID-19 disease, was carried out. Searches were also carried out through Google and Google Scholar for publications of Health organizations in reference to diagnostic methods. Results: a significant number of diagnostic tests are presented, based on different technologies, which play a key role in the COVID-19 pandemic. Some of them are very sophisticated, such as next-generation genomic sequencing, others more standard, but equally robust, such as polymerase chain reaction. Also others adapted for the pandemic outbreak such as loop-mediated isothermal amplification of nucleic acids. All of the aforementioned are considered molecular, but there are also serological tests, such as ELISA, which include plasma or immunological tests. These serve to detect antibodies against exposure to the virus or antigens in potentially infected people. Conclusions: biotechnological research and development processes applied to diagnosis and previous scientific knowledge allowed a rapid and effective national and international response in the midst of an unprecedented global pandemic. In this review we highlight the main techniques, at what stage they should be used and what information they provide us. (AU)

Discursos dos cursos da área da saúde sobre gênero e biotecnologias no âmbito da formação / Discursos de los cursos de salud sobre género y biotecnologías en el contexto de la formación / Discourses of health courses on gender and biotechnologies in the context of training

RESUMO Objetivo: investigar os discursos sobre gênero e biotecnologias no âmbito da formação dos cursos da área da saúde. Metodologia: trata-se de uma pesquisa qualitativa exploratória descritiva que está alicerçada em um estudo maior - projeto de pesquisa - desenvolvido pelo Grupo de Estudos e Pesquisas em Saúde (GEPS), intitulado "Gênero e Biotecnologias: Interfaces entre discursos e instituições na formação de alunos dos cursos da área da saúde". A pesquisa ocorreu entre os meses de março e outubro de 2019, sendo realizada por meio de entrevistas semiestruturadas com estudantes brasileiros e espanhóis da área da saúde, gravadas em áudio e transcritas para Análise do Discurso. Resultados e Discussão: os achados indicam que Gênero e Biotecnologia são temáticas que não subsidiam as discussões da formação de futuros profissionais da saúde, mostrando um entendimento de gênero centrado numa norma binária, não havendo espaço para outras possibilidades identitárias, além de a heterossexualidade ser vista como padrão de comportamento a ser seguido. Percebe-se uma certa complexidade na formulação dos discursos dos estudantes no que se refere aos aspectos em que gênero e biotecnologias escapam da relação entre corpo biológico e utilização tecnológica para esses enquadramentos físicos e mentais. Considerações Finais: as discussões sobre gênero e biotecnologias nas universidades estudadas têm sido realizadas de forma isolada, sendo necessária uma reestruturação de seus currículos de modo que os temas apresentados passem a ser contemplados para que, efetivamente, componham a formação equitativa e integral de profissionais.

RESUMEN Objetivo: investigar los discursos sobre género y biotecnologías en el contexto de la formación de los cursos de salud. Metodología: se trata de una investigación exploratoria descriptiva cualitativa que se basa en un estudio más amplio -proyecto de investigación- desarrollado por el Grupo de Estudios e Investigación en Salud (GEPS), titulado: "Género y Biotecnologías: Interfaces entre discursos e instituciones en la formación de estudiantes de cursos de salud", que se produjo entre los meses de marzo y octubre de 2019 a través de entrevistas semiestructuradas, con estudiantes de salud brasileños y españoles, grabadas en audio y transcritas para el Análisis del Discurso. Resultados y discusión: los hallazgos indican que el Género y la Biotecnología son temas que no subsidian las discusiones de la formación de los futuros profesionales de la salud, mostrando una comprensión del género centrada en una norma binaria en la que no hay espacio para otras posibilidades de identidad y la heterosexualidad como norma de comportamiento a seguir. Se percibe cierta complejidad en la formulación de los discursos de los estudiantes, en cuanto a los aspectos en los que el género y las biotecnologías escapan de la relación entre el cuerpo biológico y el uso de la tecnología para estos marcos físicos y mentales. Consideraciones finales: las discusiones sobre género y biotecnologías en las universidades brasileñas y españolas se han llevado a cabo de forma aislada, y es necesario reestructurar estos planes de estudio para que los temas presentados puedan ser contemplados en los planes de estudio para que efectivamente compongan la formación equitativa e integral de los profesionales.

ABSTRACT Objective: to investigate the discourses on gender and biotechnologies within the training of health courses. Methodology: this is a qualitative, exploratory, and descriptive study that is based on a larger study - a research project - developed by the Studies and Research Group in Health (GEPS), entitled "Gender and Biotechnologies: Interfaces between discourses and institutions in the training of students from health courses." The research took place between March and October 2019 and was carried out through semi-structured interviews with Brazilian and Spanish health students, audio-recorded, and transcribed for Discourse Analysis. Results and Discussion: the findings indicate that Gender and Biotechnology are themes that do not subsidize the discussions of the training of future health professionals, showing an understanding of gender centered on a binary norm, with no space for other identity possibilities besides heterosexuality being seen as a standard of behavior to be followed. A certain complexity is perceived in the formulation of the students' speeches regarding the aspects in which gender and biotechnologies escape from the relationship between the biological body and the technological use for these physical and mental frameworks. Final Considerations: the discussions about gender and biotechnologies in the studied universities have been carried out in an isolated way, making it necessary to restructure their curricula so that the themes presented can be contemplated to effectively compose the equitable and integral formation of professionals.

La variante SARS-CoV-2 ómicron / SARS-CoV-2 omicron variant

Introducción: A finales de noviembre de 2021, la Organización Mundial de la Salud (OMS) designó a la cepa conocida como B.1.1.529 como una variante de preocupación y le otorgó la designación ómicron, con lo cual se convierte en la cuarta variante de preocupación enumerada, junto con las variantes alfa, beta, gamma y delta. El propósito de este estudio es presentar información de la aparición, características y algunos datos de la variante ómicron. Conclusiones: Las deficientes infraestructuras en los sistemas de salud que hay en nuestro país, la baja tasa de vacunación y la presencia de comorbilidades e inmunodeficiencia en la población inducen a que ésta sea más susceptible a la infección de estas nuevas variantes. Se requiere un esfuerzo global del gobierno, las industrias farmacéuticas/biotecnológicas y las instituciones académicas y sanitarias para contener eficazmente esta pandemia (AU)

Introduction: In late November 2021, the World Health Organization (WHO) designated the strain known as B.1.1.529 as a variant of concern, and granted it the omicron designation, making it the fourth variant of concern listed along with alpha, beta, gamma, and delta variants. The purpose of the study is to present information on the occurrence, characteristics and some data on the omicron variant. Conclusions: The deficient health infrastructures present in our country, the low vaccination rate and the presence of population with comorbidities and immunodeficiency or both, are more susceptible to infection to these new variants. A global effort by the government, pharmaceutical/biotechnology industries, and academic and health institutions is required to effectively contain this pandemic (AU)

Desafios bioéticos na sociedade tecnológica / Bioethical challenges in the technological society

Há 50 anos atrás, Van Rensselaer Potter, considerado pai da Bioética, publicou Bioética: ponte para o futuro. Mesmo sendo uma disciplina relativamente recente, e ainda enfrentando o desafio de consolidar-se, a Bioética deve dar respostas à questões antigas e novas, conforme evidenciado napandemia deCovid-19. Na primeira parte deste trabalho, apresentam-se alguns dilemas actuais, que são possíveis pela tecnologia disponível. Utilizam-se casos dos últimos cinco anos, para ilustrar como o uso das novas biotecnologias exigem uma reflexão bioética, necessária tanto para os sujeitos envolvidos directamente, como para a sociedade em geral. Consideramos que o progresso, para que seja verdadeiro, deve ser um avanço na direcção correcta. Ou seja, a tecnologia por si só não basta para o progresso dahumanidade, é necessário que o seu uso favoreça a pessoa humana e a sociedade, sempre respeitando os direitos e considerando os deveres. A segunda parte concentra-sena origem, actualidade e horizonteda na Bioética. Revisam-se alguns dos acontecimentos mais importantes no seu desenvolvimento, desde a primeira vez que a palavra foi usada em 1927, até os desafios que se preveem nas próximas décadas. Conclui-se com a necessidade de uma Bioética verdadeiramente global, com métodose princípios consolidados, e capaz de dar respostas aos dilemas actuais. Portanto, os três desafios principais possivelmentesão: ampliar a visão, contar com um fundamento antropológico, e ser capaz de ser pró-activa

Fifty years ago, Van Rensselaer Potter, considered the father of bioethics, published Bioethics: Bridge to the Future. Even as a relatively recent discipline, and still facing the challenge of consolidating itself, bioethics must provide answers to old and new questions, as evidenced in the present pandemic of Covid-19. In the first part of this paper, some current dilemmas, which are made possible by the technology available today, are presented. Cases from the last five years are used to illustrate how the use of new biotechnologies requires a bioethical reflection, necessary both for the subjects directly involved and for society in general. We consider that progress, in order to be true, must be an advance in the right direction. In other words,technology alone is not enough for the progress of humanity, it is necessary that its use favours the human person and society, always respecting rights and considering duties. The second part focuses on bioethics, its origin, current affairs and horizon.Some of the most important events in the development of bioethics are reviewed, from the first time the word was used in 1927 to the challenges that are foreseen in the coming decades. It concludes with the need for a truly global Bioethics, with consolidated methods and principles, and capable of providing answers to current dilemmas. Therefore, the three main challenges are possibly: broadening the vision, having an anthropological foundation, and being able to be proactive.

Multiplicidade e instabilidade ontológica nos corações não-humanos / Multiplicity and ontological instability in nonhuman hearts

Resumo O artigo reflete sobre as relações entre corpos biológicos e artefatos tecnológicos, a partir da pesquisa etnográfica sobre o desenvolvimento de tecnologias de assistência circulatória, conhecidas como corações artificiais. Para compreender as corporeidades que tais dispositivos mecânicos ajudam a produzir, buscamos aqui caracterizar dois tipos de corpos instituídos a partir de práticas médicas e biotecnologias projetadas para pacientes com insuficiência cardíaca avançada. Os corpos imunológicos, produzidos a partir dos transplantes de coração, serão contrastados aos corpos biônicos, compostos pelo arranjo com corações artificiais. Propomos que é preciso considerar que cada uma dessas tecnologias se coproduz com distintas naturezas, sustentadas em materialidades, práticas, moralidades e pressupostos específicos. A atenção dada às práticas e à materialidade permitirá destacar os diversos entrelaçamentos materiais-semióticos. Resgatar a trajetória de desenvolvimento desse campo nos permitirá explorar o imaginário a partir do qual tais intervenções emergem, assim como as transformações ocorridas, ressaltando o vínculo ao corpo-máquina tecido no âmbito biomédico.

Abstract This paper reflects on the relationship between biological bodies and technological artifacts, based on ethnographic research on the development of circulatory assist technologies, known as artificial hearts. To understand the embodiment that such mechanical devices help to produce, we aim to characterize two types of bodies enacted from medical practices and biotechnologies designed for patients with advanced heart failure. The immunological bodies, produced from heart transplantation, will be contrasted with the bionic bodies, composed of the assembly with artificial hearts. We propose that it is necessary to consider each of these technologies as co-produced with different natures, supported by specific materialities, practices, moralities and assumptions. The attention given to practices and materiality will allow to highlight the various material-semiotic intertwinings. Tracing the development trajectory of this field will allow exploring the imagination from which such interventions emerge and the transformations that have occurred, emphasizing the link to the body-machine woven in the biomedical scope.

Silenciamiento génico en insectos plaga que afectan la industria agrícola usando ARN de interferencia / Gene silencing in pest insects that affect the agricultural industry using interference RNA

Resumen Los insectos plaga, son especies de organismos vivos que en forma constante se encuentran en poblaciones altas, ocasionando daños económicos en los cultivos. Generalmente, suele tratarse de especies puntuales, por lo general, sólo una o dos, que pueden causar gran afectación económica en el sector de la agricultura. En las últimas 3 décadas se ha venido desarrollando el concepto de un proceso biológico, detectado en eucariotas ampliamente, mediante el que se pueden silenciar genes, a partir de ARN de doble cadena (ARNdc). Esta maquinaria se ha investigado para conocer su funcionamiento y buscar potenciales aplicaciones que podrían tener en el campo de la biotecnología. En varios estudios se encontró que el silenciamiento de genes se debe a las interacciones enzimáticas intracelulares citoplasmáticas con moléculas de ARN pequeñas (ARNsi), que actúan sobre el ARN mensajero (ARNm) intracelular, impidiendo que este se traduzca a proteína. Mediante este mecanismo se busca silenciar genes específicos en insectos plaga, que sean esenciales para que el insecto pueda vivir y de esa manera evitar la proliferación de la plaga. Este artículo recopila los estudios realizados acerca del ARN de interferencia, referidos al mecanismo genético de los insectos, como alternativa para su control.

AbstractPest insects are species of living organisms that are constantly found in high populations,causing economic crops damage. Generally, it tends to be specific species, usually onlyone or two, which can cause great economic damage in the agricultural sector. In thelast 3 decades, the concept of a biological process has been developed, widely detected in eukaryotes, by which genes can be silenced, from double-stranded RNA (dsRNA). This machinery has been investigated to understand its operation and to look for potential applications that it could have in the field of biotechnology. In several studies it was found that gene silencing is due to cytoplasmic intracellular enzymatic interactions with small RNA molecules (siRNA), which act on intracellular messenger RNA (mRNA), preventing it from translating a protein. Through this mechanism, the aim is to silence specific genes in pest insects, which are essential for the insect to live and thus prevent the proliferation of the pest. This article compiles the studies carried out on RNA interference, referring to the genetic mechanism of insects, as an alternative for its control.

Difusão e propaganda sobre antienvelhecimento na mídia brasileira: um estudo de representações sociais / Diffusion and propaganda about anti-aging in brazilian media: a study of social representations / Difusión y propaganda sobre el antienvejecimiento en los medios de comunicación brasileños: un estudio de las representaciones sociales

Esta pesquisa buscou mapear conteúdos relativos ao antienvelhecimento em revistas de grande circulação e no noticiário brasileiro, entre 1º de janeiro de 2016 e 31 de dezembro de 2019. Foram investigadas as revistas Claudia, Boa Forma, VIP e Carbono Uomo. Houve ainda coleta no portal de notícias G1, da Rede Globo de Televisão, voltado ao público geral. Foram criados dois corpora distintos formados pelos conteúdos do G1 e das revistas que, então, foram submetidos à Classificação Hierárquica Descendente pelo software IRaMuTeQ, dando origem a dois subcorpora e quatro classes para cada um. Os resultados apontam uma forte tendência mercadológica nas revistas, que buscam conduzir os leitores ao consumo de produtos e à realização de procedimentos estéticos. Por outro lado, as notícias jornalísticas apregoam um modelo de vida mais saudável como principal prática antienvelhecimento, ao mesmo tempo que alertam sobre os riscos envolvidos nos procedimentos e produtos estéticos irregulares. Em geral, o conteúdo das revistas dissipa representações sociais que idealizam um padrão de beleza do corpo jovial, associando a velhice à fealdade, enquanto o do portal de notícias G1 voltam-se à saúde e longevidade.(AU)

This survey aimed to map anti-aging content, in magazines with wide circulation and also in Brazilian news, between January 1, 2016 and December 31, 2019. Claudia, Boa Forma, VIP and Carbono Uomo magazines were studied. News were also collected from the G1 news portal, from Globo television network, aimed at the general audience. Two distinct corpora formed by the contents of the G1 and the magazines were created, which were then submitted to the Descending Hierarchical Classification, by the IRaMuTeQ software, leading to two subcorpora and four classes for each. The results show a strong market orientation in the magazines, which aim to lead readers to purchase products and undertake aesthetic procedures. The news reports, on the other way, promote a healthier life model as the main anti-aging practice, while warning about the risks involved in irregular aesthetic procedures and products. In general, the content of the magazines spreads social representations which idealize a pattern of beauty of a young body, connecting old age with ugliness, whereas that of the G1 news portal are focused on health and longevity.(AU)

Esta iniciativa buscó mapear material de antienvejecimiento, en revistas de gran tirada y en las noticias de Brasil, entre el 1 de enero de 2016 y el 31 de diciembre de 2019. Se analizaron las revistas Claudia, Boa Forma, VIP y Carbono Uomo. También se recogieron noticias del sitio de noticias G1 y de la red de televisión Globo, ambas dirigidas al público en general. Se crearon dos corpora distintos formados por el contenido del G1 y de las revistas, que luego fueron sometidos a la Clasificación Jerárquica Descendente, por el software IRaMuTeQ, dando lugar a dos subcorpora y cuatro clases para cada uno de los corpora. Los resultados señalan una fuerte orientación del mercado de promoción en las revistas, que buscan llevar a los lectores a consumir productos y realizar procedimientos estéticos. En cambio, las noticias periodísticas difunden un modelo de vida más saludable como la principal práctica antienvejecimiento, mientras que al mismo tiempo advierten sobre los riesgos que implican los procedimientos irregulares y los productos estéticos. De forma general, el contenido de las revistas difunde representaciones sociales que idealizan un estándar de belleza del cuerpo joven, asociando la vejez con la fealdad, mientras que el del portal de noticias G1 se orienta a la salud y la longevidad.(AU)

Developing biosecurity training program under the background of new engineering education in colleges and universities / 生物工程学报

The global biosecurity situation has become increasingly severe in recent years. The threats from outbreaks of epidemics, misuse and abuse of biotechnology, biological weapons and so on are emerging, which make biosecurity an important part of national security. Meanwhile, as a new interdisciplinary program, the education for biosecurity is still in its infancy. The challenges of domestic and international biosecurity and the quick development of biosecurity industry necessitate the establishment of security disciplines, which expose the deficiencies of talent pool in the interdisciplinary field involving biosecurity in China. Especially under the background of new engineering education, the importance of biosecurity training program has become more obvious than before. On the basis of our teaching experience, we systemically introduced the specific measures to improve the training system of biosecurity in the context of new engineering education, such as establishing an integrated curriculum system, constructing innovative teaching modes, exploring general education reform plans, and perfecting continuous improvement mechanisms.

Engineering application of aerobic methane oxidizing bacteria (methanotrophs): a review / 生物工程学报

Aerobic methane oxidizing bacteria (methanotrophs) can use methane as carbon source and energy source, eliminating 10%-20% of global methane. Methanotrophs can also effectively synthesize valuable methane-derived products. This article introduced the methane oxidizing mechanism of methanotrophs, and summarized the practical application and research hotspots of methanotrophs in the field of methane emission reduction in the landfill, ventilation air methane mitigation in coal mines, valuable chemicals biosynthesis, as well as oil and gas reservoir exploration. Main factors influencing the pollutant removal and the biosynthesis efficiency in various applications were also discussed. Based on the study of large-scale cultivation of methanotrophs, some measures to benefit the application and promotion of aerobic methane oxidizing biotechnology were proposed. This includes investigating the effect of intermediate metabolites on methanotrophs activity and population structure, and exploiting economical and efficient alternative culture media and culture techniques.

Biomanufacturing driven by engineered microbes / 生物工程学报

This article summarized the reviews and research articles published in Chinese Journal of Biotechnology in the field of biomanufacturing in 2021. The article covered major chassis cells such as Escherichia coli, Bacillus subtilis, Corynebacterium glutamicum, Saccharomyces cerevisiae, filamentous fungi, non-model bacteria and non-conventional yeasts. Moreover, this article summarized the advances in the production of amino acids, organic acids, vitamins, higher alcohols, natural compounds (terpenoids, flavonoids, alkaloids), antibiotics, enzymes and enzyme-catalyzed products, biopolymers, as well as the utilization of biomass and one-carbon materials. The key technologies used in the construction of cell factories, such as regulation, evolution, and high-throughput screening, were also included. This article may help the readers better understand the R & D trend in biomanufacturing driven by engineered microbes.

Bioética e seus paradigmas teóricos / Bioethics and its theoretical paradigms / La bioética y sus paradigmas teóricos

Resumo O artigo busca contribuir para a compreensão da história e dos modelos teóricos da bioética por meio de abordagem interdisciplinar que engloba diversas áreas do conhecimento, em especial história e filosofia. Num primeiro momento, o trabalho procura caracterizar o panorama histórico de surgimento da bioética, as questões terminológicas surgidas nesse período e o enquadramento da bioética como disciplina ou campo de discursividade. Posteriormente, o texto apresenta os principais paradigmas teóricos da bioética e os analisa criticamente.

Abstract This article seeks to contribute to the understanding of the history and theoretical models of bioethics by an interdisciplinary approach that encompasses different areas of knowledge, especially history and philosophy. First, the study characterizes the historical background on the emergence of bioethics, the terminological issues that arose in this period, and the framing of bioethics as a discipline or field of discourse. Subsequently, the text presents the main theoretical paradigms of bioethics and critically analyzes them.

Resumen El artículo busca contribuir a la comprensión de la historia y los modelos teóricos de la bioética a través de un enfoque interdisciplinario que abarca varias áreas del conocimiento, especialmente la historia y la filosofía. En un primer momento, el trabajo busca caracterizar el panorama histórico del surgimiento de la Bioética, las cuestiones terminológicas surgidas en ese período y el encuadre de la bioética como disciplina o campo de discursividad. Posteriormente, el texto presenta los principales paradigmas teóricos de la Bioética y los analiza críticamente.

Uso de tecnologías de información y comunicación en el screening de la depresión asociada al consumo de sustancias psicoactivas / Use of information and communication technologies in screening of depression associated with the use of psychoactive substances

Resumen Introducción. El consumo de sustancias psicoactivas (SPA) se consideran como una enfermedad crónica debido a que el inicio, curso, dirección, y resultado es impredecible en algunos casos y adicionalmente son trastornos multicausales como es el caso de la depresión; según datos reportados por el Centro de Adicciones de Barcelona "la incidencia de depresión en pacientes con abuso de sustancias oscila entre el 6% y 70% en los consumidores de SPA". Con este panorama se debe comprender que la intervención debe desarrollar la promoción de la salud y la prevención de la enfermedad, con la aparición de la biotecnología con el uso y aplicación de las tecnologías de la información y las comunicaciones (TIC) en las ciencias de salud y la vida para el diagnóstico, prevención, supervisión, tratamiento. Objetivo. Desarrollar un software que permita generar una alerta para la identificación temprana de la depresión asociada al consumo de sustancias psicoactivas en adultos, mediante el uso de una TICs previamente validada, durante el año 2019. Metodología. Investigación Tecnológica, utilizando la metodología "UWE" con enfoque al desarrollo de software para el dominio web. Resultados. En esta propuesta de investigación se avanzará en el desarrollo del prototipo del producto para la identificación temprana de la depresión con el fin de mejorar el proceso de toma de decisiones clínicas, en el momento mismo de la atención, con base en la información registrada en el software llamado MEASDEP (Medición de la depresión en consumidores de SPA).

Abstract Introduction. The consumption of psychoactive substances (SPA) is considered a chronic disease because the onset, course, direction, and result is unpredictable in some cases and additionally they are multi-causal disorders such as depression; according to data reported by the Barcelona Addiction Center "the incidence of depression in patients with substance abuse ranges between 6% and 70% in SPA users". With this outlook, it should be understood that the intervention should develop the promotion of health and the prevention of disease, with the appearance of biotechnology with the use and application of information and communication technologies (ICT) in science, health and life for diagnosis, prevention, supervision, treatment. Objective. To develop a software that allows generating an alert for the early identification of depression associated with the use of psychoactive substances in adults, through the use of a previously validated ICT, during 2019. Methodology. Technological Research, using the "UWE "With a focus on software development for the web domain. Results. In this research proposal, progress will be made in the development of the product prototype for the early identification of depression in order to improve the clinical decision-making process, at the moment of care, based on the registered information in the software called MEASDEP (Measurement of depression in SPA consumers).

Efeito de um treinamento com realidade virtual não imersiva sobre a execução da tarefa motora real em idosos: relato de casos / Effect of training with non-imersive virtual reality on the performance of the real motor task in the elderly: case reports

| INTRODUÇÃO: No contexto de reabilitação em gerontologia surge como destaque a melhoria da capacidade de execução de tarefas motoras a fim de promover a autonomia, dessa maneira, é preciso investigar ferramentas para viabilizar esse objetivo clinico. OBJETIVO: Avaliar o efeito de um treino com realidade virtual não imersiva sobre a execução da tarefa motora real em idosos. MATERIAIS E MÉTODO: Trata-se de um relato de casos, com intervenção única, utilizando o Nintendo® Wii com sujeitos de idade superior a 60 anos submetidos à intervenção com treinamento de arremesso no jogo wii sports resort, e avaliados com analise cinemática angular de vídeo com o software Kinovea®, antes e depois da intervenção, protocolo composto por uma bateria de dez arremessos, antes e após a intervenção, além da avaliação subjetiva da melhora pós-treino. RESULTADOS: Participaram da pesquisa 4 sujeitos, sendo 3 do sexo feminino, com média de idade 70,7 anos ± 7,13 e escolaridade 8 anos ± 6,16. Para as variáveis angulares verificou-se que, após o treino com Wii, houve acentuação na flexão de ombro e decréscimo no cotovelo para na postura inicial do arremesso; já na posição final do arremesso, ocorreu decréscimo na extensão de cotovelo e aumento da flexão de punho. Também foi verificado aumento do salto e diminuição no tempo de execução da tarefa. CONSIDERAÇÕES FINAIS: Diante disso é possível concluir que o Nintendo® Wii se mostra um recurso potencial para melhoria de gestos no âmbito real para idosos.

INTRODUCTION: In the context of rehabilitation in gerontology, the improvement of the ability to perform motor tasks is highlighted to promote autonomy, so it is necessary to investigate tools to achieve this clinical objective. OBJECTIVE: To evaluate the effect of training with non-immersive virtual reality on the execution of the real motor task in the elderly. MATERIALS AND METHOD: This is a case report, with a single intervention using the Nintendo® Wii, with subjects over 60 years old who underwent intervention with throw training in the game Wii sports resort and evaluated with video angular kinematic analysis with the Kinovea® software before and after the intervention, a protocol consisting of a battery of ten shots before and after the intervention, in addition to the subjective assessment of posttraining improvement. RESULTS: Four subjects participated in the research, 3 females, with a mean age of 70.7 years ± 7.13 and schooling 8 years ± 6.16. For the angular variables, it was found that, after training with the Wii, in the initial throwing posture, there was an accentuation in the shoulder flexion and a decrease in the elbow for the same movement in the final position. There was a decrease in the elbow extension and an increase in the wrist flexion. It was also verified an increase in the jump and a decrease in the task execution time. FINAL CONSIDERATIONS: Given this, it is possible to conclude that the Nintendo® Wii is a potential resource for improving gestures in real life for the elderly

Media development and process parameter optimization using statistical experimental designs for the production of nonribosomal peptides in Escherichia coli

BACKGROUND: Nonribosomal peptide synthases (NRPS) can synthesize functionally diverse bioactive peptides by incorporating nonproteinogenic amino acids, offering a rich source of new drug leads. The bacterium Escherichia coli is a well-characterized production host and a promising candidate for the synthesis of nonribosomal peptides, but only limited bioprocess engineering has been reported for such molecules. We therefore developed a medium and optimized process parameters using the design of experiments (DoE) approach. RESULTS: We found that glycerol is not suitable as a carbon source for rhabdopeptide production, at least for the NRPS used for this study. Alternative carbon sources from the tricarboxylic acid cycle achieved much higher yields. DoE was used to optimize the pH and temperature in a stirred-tank reactor, revealing that optimal growth and optimal production required substantially different conditions. CONCLUSIONS: We developed a chemically defined adapted M9 medium matching the performance of complex medium (lysogeny broth) in terms of product concentration. The maximum yield in the reactor under optimized conditions was 126 mg L-1, representing a 31-fold increase compared to the first shaking-flask experiments with M9 medium and glycerol as the carbon source. Conditions that promoted cell growth tended to inhibit NRPS productivity. The challenge was therefore to find a compromise between these factors as the basis for further process development.

Biorreactores de un solo uso en la industria biofarmacéutica y su uso en la producción de candidatos vacunales contra SARS- COV-2. Artículo de revisión / Single-use systems bioreactors in the biopharmaceutical industry and its use in SARS-CoV-2 vaccine's candidates production. A review

Los biorreactores de sistemas de un solo uso (SUSs), también conocidos como biorreactores desechables, se han convertido en una parte integral de las instalaciones biotecnológicas de fabricación para bioproductos con un mercado potencial que espera una tasa de crecimiento de casi el 15,5% durante el período pronosticado: 2018 a 2023. Los biorreactores SUSs son más seguros, simples y flexibles al compararlos con sus contrapartes, biorreactores de acero inoxidable, por lo que su uso se está incrementando en la industria biofarmacéutica principalmente en la planificación de vías rápidas de proyectos complejos, incluidos los relacionados con la pandemia de SARS-CoV-2. Así, el uso de SUS se ha convertido en una alternativa eficaz para la producción rápida de candidatos a vacunas. Pero algunas desventajas técnicas y operativas aún obstaculizan su uso en todo el mundo. Esta revisión brinda una visión racional del uso, los tipos, los parámetros operativos y las nuevas aplicaciones de los biorreactores SUSs en la industria biofarmacéutica. Asimismo, también se discuten los parámetros apropiados y las limitaciones de este equipo, enfocándose en su uso para la producción de vacunas contra COVID-19

Single-Use-Systems (SUSs) Bioreactors, also known as disposable bioreactors, have become an integral part of biotechnology manufacturing facilities for bioproducts with a potential market expecting a growth rate of nearly 15.5% over the forecast period: 2018 to 2023. SUSs bioreactors are comparatively safe, simple, and flexible than their stainless-steel bioreactors counterparts thus, their usage is being augmented in the biopharmaceutical industry mainly in planning fast tracks of complex projects, including those related to the SARS-CoV-2 pandemic. Thus, the use of SUSs has become an effective alternative for the rapid production of vaccine candidates. However, some technical and operational disadvantages still hamper their worldwide use. This review gives a rational insight into SUSs bioreactors use, types, operational parameters and new applications in the biopharmaceutical industry. Likewise, the appropriate parameters and limitations of this equipment, focusing on its use for vaccine production against COVID-19 are also discussed